|
|
Dr. Steiner was born in From 1986-1992, Dr.
Steiner served his residency in general surgery and urology at the From 1993-1995, he was a
member of the faculty of Vanderbilt University School of Medicine as an
Assistant Professor of Urology, Cell Biology and Pathology and specialized in
clinical urologic oncology. Dr.
Steiner did postdoctoral research at Vanderbilt as the Ortho Scholar of the
American Foundation for Urologic Research and worked with Dr. Harold Moses
studying the role of peptide growth factors in prostate carcinogenesis. In 1995 Dr. Steiner
joined the faculty of The University of Tennessee, Memphis College of
Medicine, as Associate Professor of Urology and Pharmacology and Director of
Urologic Oncology. In June 1995
he was named the Mark S. Soloway Professor of Urology, Chair of
Excellence. Dr. Steiner served as Professor
and Chairman of the Department of Urology, The University of Tennessee, Dr. Steiner is a Diplomat
of the American Board of Urology and a Fellow of the Dr. Steiner has conducted
independent laboratory cancer research since 1980 and has been a recipient of
NIH RO1s, Department of Defense, and CaP CURE Grants. He was a member of the Cancer Leukemia
Group B Intergroup study section. He serves as a member of
the editorial board of Gene Therapy and Molecular Biology Journal, past
Editor-in-Chief of the World Journal of Urology, Section Editor of Prostate
Cancer section of Current Opinions in Urology, and was a member of the NIH,
NCI, American Foundation for Urologic Disease and American Cancer Society
study sections. He also serves as
the Research Editor for the World Journal of Urology and is a Reviewer of
Urology, Journal of Urology, Human Pathology, International Journal of Cancer
and Urologic Oncology. He has authored over 200
abstracts and publications and has 276 patents issued and/or pending. Dr. Steiner is currently
a Professor at The University of Tennessee, |
